DK0611397T3 - Vaccine mod katteleukæmivirus - Google Patents

Vaccine mod katteleukæmivirus

Info

Publication number
DK0611397T3
DK0611397T3 DK92922254T DK92922254T DK0611397T3 DK 0611397 T3 DK0611397 T3 DK 0611397T3 DK 92922254 T DK92922254 T DK 92922254T DK 92922254 T DK92922254 T DK 92922254T DK 0611397 T3 DK0611397 T3 DK 0611397T3
Authority
DK
Denmark
Prior art keywords
leukemia virus
vaccine against
against cat
cat leukemia
vaccine
Prior art date
Application number
DK92922254T
Other languages
English (en)
Inventor
Richard Calvert Wardley
Darrell Ray Thomsen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0611397T3 publication Critical patent/DK0611397T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK92922254T 1991-11-08 1992-10-08 Vaccine mod katteleukæmivirus DK0611397T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78916391A 1991-11-08 1991-11-08
US85706492A 1992-03-25 1992-03-25
PCT/US1992/008427 WO1993009238A1 (en) 1991-11-08 1992-10-08 Feline leukemia virus vaccines

Publications (1)

Publication Number Publication Date
DK0611397T3 true DK0611397T3 (da) 2002-10-07

Family

ID=27120881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92922254T DK0611397T3 (da) 1991-11-08 1992-10-08 Vaccine mod katteleukæmivirus

Country Status (12)

Country Link
EP (2) EP0611397B1 (da)
JP (1) JP2852395B2 (da)
KR (1) KR100265393B1 (da)
AT (1) ATE219520T1 (da)
AU (2) AU672372B2 (da)
CA (1) CA2120137C (da)
DE (1) DE69232650T2 (da)
DK (1) DK0611397T3 (da)
ES (1) ES2177530T3 (da)
LV (1) LV13060B (da)
MX (1) MX9206018A (da)
WO (1) WO1993009238A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090379A (en) * 1992-04-29 2000-07-18 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle for use in recombinant protein production and pesticides
ES2203617T3 (es) * 1992-04-29 2004-04-16 Boyce Thompson Institute For Plant Research, Inc. Infeccion oral de larvas de insectos con particulas de baculovirus pre-ocluidos.
US5593669A (en) * 1992-04-29 1997-01-14 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle
FR2715664B1 (fr) * 1994-01-31 1996-04-12 Proteine Performance Sa Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
ATE381624T1 (de) 1994-05-09 2008-01-15 Oxford Biomedica Ltd Retrovirale vektoren mit verminderter rekombinationsrate
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US6248582B1 (en) * 1997-10-08 2001-06-19 Imran Khan Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV
KR20190062084A (ko) 2017-11-28 2019-06-05 주식회사 제트바이오텍 고양이 백혈병 바이러스 검출용 프라이머 및 이를 포함한 진단 키트
CN109679970B (zh) * 2018-11-20 2020-12-08 杭州贤至生物科技有限公司 猫疱疹i型病毒快速检测的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173997A1 (en) * 1984-09-06 1986-03-12 Chiron Corporation Feline leukemia virus protein vaccines and their preparation
AU607399B2 (en) * 1985-09-09 1991-03-07 Cetus Corporation Infectious recombinant virus vaccine for feline leukemia
ZA867281B (en) * 1985-09-25 1987-05-27 Oncogen Vaccines and immunoassays for acquired immune deficiency syndrome
NZ217645A (en) * 1985-09-25 1991-11-26 Oncogen Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations
GB8523999D0 (en) * 1985-09-30 1985-11-06 Jabay Ltd Injection of liquid into meat
JP2656521B2 (ja) * 1986-05-30 1997-09-24 ケンブリッジ・バイオサイエンス・コーポレーション ネコ白血病ウイルス抗原の製造法と用途
AU4194089A (en) * 1988-08-08 1990-03-05 Cetus Corporation Methods for isolating herpes virus thymidine kinase-encoding dna
CA2068713A1 (en) * 1989-11-20 1991-05-21 Omar K. Haffar Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens

Also Published As

Publication number Publication date
AU2892392A (en) 1993-06-07
AU4213496A (en) 1996-04-26
LV13060B (en) 2003-12-20
DE69232650D1 (de) 2002-07-25
MX9206018A (es) 1993-05-01
ATE219520T1 (de) 2002-07-15
CA2120137C (en) 2004-05-04
AU672372B2 (en) 1996-10-03
EP1136562A3 (en) 2003-06-25
DE69232650T2 (de) 2002-11-28
JP2852395B2 (ja) 1999-02-03
EP1136562A2 (en) 2001-09-26
KR100265393B1 (ko) 2000-10-02
EP0611397B1 (en) 2002-06-19
JPH06510910A (ja) 1994-12-08
CA2120137A1 (en) 1993-05-13
EP0611397A1 (en) 1994-08-24
ES2177530T3 (es) 2002-12-16
AU689355B2 (en) 1998-03-26
WO1993009238A1 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
FI923443A0 (fi) Foereningar och foerfarande foer inhibering av hiv och liknande virus.
DE68927025D1 (de) HIV-2-Virusvarianten
TR26855A (tr) Dis-tasina karsi agiz bilesimleri.
DK29989D0 (da) Bifunktionelt vaekstmodulerende glycoprotein benaevnt amphiregulin
FI880428A (fi) Ytantigener av hepatit b virus och hybridantigener innehaollande desamma.
DK0611397T3 (da) Vaccine mod katteleukæmivirus
FI891449A0 (fi) Nya 2,3,4-substituerade imidazoler och 3,4,5-substituerade 1,2,4-triazoler, deras framstaellning och anvaendning.
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
DK62486A (da) Vaccine mod malaria
DE68918359T2 (de) Handabtastdrucker.
ES2104752T3 (es) Materiales dentales a base de (met)acrilatos.
FI890285A (fi) Nya aminosyraglycerider, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
DE58904845D1 (de) Zahnaerztliches saughandstueck.
FI922954A (fi) Nya glykopeptider, foerfarande foer deras framstaellning och deras anvaendning
KR950700933A (ko) 사람 면역결핍 바이러스(HIV) 표면 당단백질로부터 유래된 합성 폴리펩타이드(Synthetic polypeptides derived from the HIV envelope glycoprotein)
FI934777A0 (fi) Multipel hepatitis b virus ytproteiner som bildar partiklar
DE59204210D1 (de) Zahnärztliches handstück.
MX9206973A (es) Vacuna a base de virus del herpes bovino modificado tipo 1.
ES2083428T3 (es) Uso de derivados de isoxazolin-3-ona como antidepresivos.
NO891691D0 (no) Rekombinant gag-forloeper for hiv.
NO901959D0 (no) Malaria-vaksine.
FI894268A (fi) Kolvkonstruktion och foerfarande foer att montera den.
DE59009900D1 (de) Emitterfolger-Schaltungsanordnung.
NO891355L (no) Vaksinasjon mot rabis-beslektede virus.
NO910350D0 (no) Fly/helikopter.